Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tomeny

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Bulletin of the World Health Organization|June 10, 2020
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trialJason J Madan, Laura Rosu, Mamo Girma Tefera, et al.
Systematic Reviews|November 11, 2025
Development of a PRISMA extension for systematic reviews of health economic evaluations (PRISMA-EconEval): a project protocolPhuong Bich Tran, Joseph Kwon, Andrew Booth, et al.
BMJ Global Health|May 23, 2022
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban MalawiEwan M Tomeny, Rebecca Nightingale, Beatrice Chinoko, et al.
The Lancet. Global Health|November 10, 2021
Palliative care and catastrophic costs in Malawi after a diagnosis of advanced cancer: a prospective cohort studyMaya Jane Bates, Miriam R P Gordon, Stephen B Gordon, et al.
The Lancet. Global Health|December 24, 2022
Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trialLaura Rosu, Jason J Madan, Ewan M Tomeny, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Bulletin of the World Health Organization|June 10, 2020
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trialJason J Madan, Laura Rosu, Mamo Girma Tefera, et al.
Systematic Reviews|November 11, 2025
Development of a PRISMA extension for systematic reviews of health economic evaluations (PRISMA-EconEval): a project protocolPhuong Bich Tran, Joseph Kwon, Andrew Booth, et al.
BMJ Global Health|May 23, 2022
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban MalawiEwan M Tomeny, Rebecca Nightingale, Beatrice Chinoko, et al.
The Lancet. Global Health|November 10, 2021
Palliative care and catastrophic costs in Malawi after a diagnosis of advanced cancer: a prospective cohort studyMaya Jane Bates, Miriam R P Gordon, Stephen B Gordon, et al.
The Lancet. Global Health|December 24, 2022
Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trialLaura Rosu, Jason J Madan, Ewan M Tomeny, et al.
Pageof 2